Concepedia

Shabnam Tangri

ST

Statistics

Publications

19

Citations

2K

H-Index

17

Active since

1991

Affiliations

Biogen (United States)(Current)

Pfizer (United States)

Novartis (United States)

Bristol-Myers Squibb (United States)

United States Food and Drug Administration

Shabnam Tangri is an author at Biogen (United States) specializing in medicine, immunology, and immunotherapy.

Top concepts

MedicineImmunologyImmunotherapyAutoimmunityAutoimmune DiseaseHistocompatibilityAllergyPathologyCell BiologyImmunodominance

Publications per year

1991–2022

19

Publications

19

CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice.

S Cardell, Shabnam Tangri, Susan Chan et al. · The Journal of Experimental Medicine · 1995 · 381 citations · Full text

Histocompatibility, Cd4+ T, Autoimmune Disease +15

Peptide Binding and Presentation by Mouse CD1

A. Raúl Castaño, Shabnam Tangri, Jeffrey E. Miller et al. · Science · 1995 · 248 citations

Histocompatibility, Immunology, Immunologic Mechanism +16

Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti–PD-1 Therapies in Metastatic Melanoma

Douglas B. Johnson, Jennifer Bordeaux, Ju Young Kim et al. · Clinical Cancer Research · 2018 · 174 citations

Immunology, Pathology, Immunotherapeutics +21

Rationally Engineered Therapeutic Proteins with Reduced Immunogenicity

Shabnam Tangri, Bianca R. Mothé, Julie Eisenbraun et al. · The Journal of Immunology · 2005 · 166 citations

Histocompatibility, Chronic Administration, Immunology +18

Mouse CD1-Autoreactive T Cells Have Diverse Patterns of Reactivity to CD1+ Targets

Laurent Brossay, Shabnam Tangri, Mark Bix et al. · The Journal of Immunology · 1998 · 148 citations

Rows per page

1–5 of 19